AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

DEXCOM INC Director's Dealing 2020

Mar 11, 2020

30198_dirs_2020-03-10_ea76f146-d4f3-4702-8da8-8519921ba190.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: DEXCOM INC (DXCM)
CIK: 0001093557
Period of Report: 2020-03-06

Reporting Person: Sylvain Jereme M (SVP, Finance & CAO)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	8547	Direct

Footnotes

F1: Included in this number are 7,372 unvested restricted stock units, 4,824 of which were granted on March 8, 2019 and shall vest through March 8, 2022 and 2,548 of which were granted on November 8, 2018 and shall vest through November 8, 2021.